Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 8
2003 4
2004 5
2005 5
2006 8
2007 13
2008 6
2009 14
2010 16
2011 20
2012 9
2013 17
2014 21
2015 24
2016 24
2017 17
2018 16
2019 30
2020 43
2021 68
2022 51
2023 57
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

432 results

Results by year

Filters applied: . Clear all
Page 1
Tolerance induction through early feeding to prevent food allergy in infants and children with sensitization against food allergens (TIFFANI): rationale, study design, and methods of a randomized controlled trial.
Kalb B, Meixner L, Heller S, Dölle-Bierke S, Roll S, Tissen-Diabaté T, Lau S, Forslund S, Marenholz I, Lee YA, Thiel A, Babina M, Scheffel J, Worm M, Beyer K. Kalb B, et al. Among authors: worm m. Trials. 2024 Apr 19;25(1):272. doi: 10.1186/s13063-024-08114-9. Trials. 2024. PMID: 38641837 Free PMC article. Clinical Trial.
S2k‐Leitlinie: Diagnostik und Therapie der zirkumskripten Sklerodermie.
Kreuter A, Moinzadeh P, Kinberger M, Horneff G, Worm M, Werner RN, Hammacher A, Krieg T, Wenzel J, Oeschger M, Weibel L, Müllegger R, Hunzelmann N. Kreuter A, et al. Among authors: worm m. J Dtsch Dermatol Ges. 2024 Apr;22(4):605-621. doi: 10.1111/ddg.15328_g. J Dtsch Dermatol Ges. 2024. PMID: 38574014 German.
Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxoedema and scleroedema.
Knobler R, Geroldinger-Simić M, Kreuter A, Hunzelmann N, Moinzadeh P, Rongioletti F, Denton C, Mouthon L, Cutolo M, Smith V, Gabrielli A, Bagot M, Olesen AB, Foeldvari I, Jalili A, Kähäri VM, Kárpáti S, Kofoed K, Olszewska M, Panelius J, Quaglino P, Seneschal J, Sticherling M, Sunderkötter C, Tanew A, Wolf P, Worm M, Skrok A, Rudnicka L, Krieg T. Knobler R, et al. Among authors: worm m. J Eur Acad Dermatol Venereol. 2024 Mar 8. doi: 10.1111/jdv.19937. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38456518
S2k guideline: Diagnosis and therapy of localized scleroderma.
Kreuter A, Moinzadeh P, Kinberger M, Horneff G, Worm M, Werner RN, Hammacher A, Krieg T, Wenzel J, Oeschger M, Weibel L, Müllegger R, Hunzelmann N. Kreuter A, et al. Among authors: worm m. J Dtsch Dermatol Ges. 2024 Apr;22(4):605-620. doi: 10.1111/ddg.15328. Epub 2024 Mar 1. J Dtsch Dermatol Ges. 2024. PMID: 38426689
Updated grading system for systemic allergic reactions: Joint Statement of the World Allergy Organization Anaphylaxis Committee and Allergen Immunotherapy Committee.
Turner PJ, Ansotegui IJ, Campbell DE, Cardona V, Carr S, Custovic A, Durham S, Ebisawa M, Geller M, Gonzalez-Estrada A, Greenberger PA, Hossny E, Irani C, Leung ASY, Levin ME, Muraro A, Oppenheimer JJ, Ortega Martell JA, Pouessel G, Rial MJ, Senna G, Tanno LK, Wallace DV, Worm M, Morais-Almeida M; WAO Anaphylaxis Committee and WAO Allergen Immunotherapy Committee. Turner PJ, et al. Among authors: worm m. World Allergy Organ J. 2024 Feb 10;17(3):100876. doi: 10.1016/j.waojou.2024.100876. eCollection 2024 Mar. World Allergy Organ J. 2024. PMID: 38361745 Free PMC article. Review.
S3-Leitlinie Atopische Dermatitis: Teil 2 - Systemische Therapie: S3 guideline Atopic dermatitis: Part 2 - Systemic treatment.
Werfel T, Heratizadeh A, Aberer W, Augustin M, Biedermann T, Bauer A, Fölster-Holst R, Kahle J, Kinberger M, Nemat K, Neustädter I, Peters E, von Kiedrowski R, Schmid-Grendelmeier P, Schmitt J, Schwennesen T, Simon D, Spindler T, Traidl-Hoffmann C, Werner RN, Wollenberg A, Worm M, Ott H. Werfel T, et al. Among authors: worm m. J Dtsch Dermatol Ges. 2024 Feb;22(2):307-322. doi: 10.1111/ddg.15229_g. J Dtsch Dermatol Ges. 2024. PMID: 38361206 Free article.
Dupilumab treatment improves signs, symptoms, quality of life, and work productivity in patients with atopic hand and foot dermatitis: Results from a phase 3, randomized, double-blind, placebo-controlled trial.
Simpson EL, Silverberg JI, Worm M, Honari G, Masuda K, Syguła E, Schuttelaar MLA, Mortensen E, Laws E, Akinlade B, Patel N, Maloney J, Paleczny H, Delevry D, Xiao J, Dubost-Brama A, Bansal A. Simpson EL, et al. Among authors: worm m. J Am Acad Dermatol. 2024 Feb 1:S0190-9622(24)00146-4. doi: 10.1016/j.jaad.2023.12.066. Online ahead of print. J Am Acad Dermatol. 2024. PMID: 38296199 Free article.
Genetic Association and Differential RNA Expression of Histone (De)Acetylation-Related Genes in Pemphigus Foliaceus-A Possible Epigenetic Effect in the Autoimmune Response.
Sulzbach Denardin M, Bumiller-Bini Hoch V, Salviano-Silva A, Lobo-Alves SC, Adelman Cipolla G, Malheiros D, Augusto DG, Wittig M, Franke A, Pföhler C, Worm M, van Beek N, Goebeler M, Sárdy M, Ibrahim S, Busch H, Schmidt E, Hundt JE, Petzl-Erler ML, Beate Winter Boldt A. Sulzbach Denardin M, et al. Among authors: worm m. Life (Basel). 2023 Dec 29;14(1):60. doi: 10.3390/life14010060. Life (Basel). 2023. PMID: 38255677 Free PMC article.
Clinical benefits with 300 IR HDM SLIT tablet in Europeans with house dust mite allergic rhinitis: Post hoc analysis of a large phase 3 trial.
Pfaar O, De Blay F, Canonica GW, Casale TB, Gevaert P, Hellings PW, Kowal K, Passalacqua G, Tortajada-Girbés M, Vidal C, Worm M, Bahbah F, Demoly P. Pfaar O, et al. Among authors: worm m. World Allergy Organ J. 2023 Dec 22;17(1):100849. doi: 10.1016/j.waojou.2023.100849. eCollection 2024 Jan. World Allergy Organ J. 2023. PMID: 38225952 Free PMC article.
432 results